Cited by

McCollum, 138 N.H. at 287-88; see also Raymond v. Eli Lilly & Co., 117 N.H. 164, 170, 173-74 (1977).

In this jurisdiction the discovery rule has traditionally been deemed equitable, see Rowe v. John Deere, 130 N.H. 18, 22-23, 533 A.2d 375, 377 (1987); Raymond v. Eli Lilly & Co., 117 N.H. 164, 170, 371 A.2d 170, 174 (1977), and the plaintiff does not argue that the codification of the rule changes this result.

Rowe v. John Deere, 130 N.H. 18, 23, 533 A.2d 375, 377 (1987); Raymond v. Eli Lilly & Co., 117 N.H. 164, 170, 371 A.2d 170, 174 (1977); Shillady v. Elliot Community Hosp., 114 N.H. 321, 325, 320 A.2d 637, 639 (1974).

The court also found that “[e]ven if the Court were to give the plaintiff the benefit of the discovery rule, the Court finds that the action would have accrued in 1987 with the discovery of the leaks because this is the type of injury which would put the plaintiff on notice that its rights had been violated, Raymond v. Eli Lilly & Co., 117 N.H. 164 (1977).

1985); Brown v. Mary Hitchcock Memorial Hosp., 117 N.H. 739, 743, 378 A.2d 1138, 1140-41 (1977); Raymond v. Eli Lilly & Co., 117 N.H. 164, 170-71, 371 A.2d 170, 173-74 (1977).

The rule was further refined in Raymond v. Eli Lilly & Co., 117 N.H. 164, 171, 371 A.2d 170, 174 (1977), a drug products liability case, and may be stated as follows: “A cause of action will not accrue.

In French v. R. S. Audley, Inc., 123 N.H. 476, 480, 464 A.2d 279, 282 (1983) (citing and extending the rule of Raymond v. Eli Lilly Co., 117 N.H. 164, 171, 371 A.2d 170, 174 (1977)), we held that “a cause of action involving harm to property will not accrue under the discovery rule until the plaintiff discovers, or in the exercise of reasonable diligence should have discovered, not only that he has been injured, but also that his injury may have been caused by the

at 480, 464 A.2d at 282 (tortious property damage); Carson v. Maurer, 120 N.H. 925, 936, 424 A.2d 825, 833 (1980) (medical malpractice); Raymond v. Eli Lilly & Co., 117 N.H. 164, 174-75, 371 A.2d 170, 176-77 (1977) (drug products liability); McKee v. Riordan, 116 N.H. 729, 730-31, 366 A.2d 472, 473 (1976) (legal malpractice).

Raymond v. Eli Lilly & Co. 117 N.H. 164, 169, 371 A.2d 170, 173 (1977).

Raymond v. Eli Lilly & Co., 117 N.H. 164, 171, 371 A.2d 170, 174 (1977) (applying discovery rule to injuries allegedly caused by medical malpractice).

Raymond v. Eli Lilly & Co., 117 N.H. 164, 171, 371 A.2d 170, 174 (1977); see United States v. Kubrick, 444 U.S. 111, 117-25 (1979).

We have previously lip plied the discovery rule generally to cases of professional malpractice, see Carson v. Maurer, 120 N.H. 925, 936, 424 A.2d 825, 833 (1980) (medical malpractice); McKee v. Riordan, 116 N.H. at 731, 366 A.2d at 473 (legal malpractice), and to drug products liability cases, Raymond v. Eli Lilly Co., 117 N.H. 164, 174-75, 371 A.2d 170, 176-77 (1977).

Raymond v. Eli Lilly & Co., 117 N.H. 164, 171, 371 A.2d 170, 174 (1977); see United States v. Kubrick, 444 U.S. 111, 118-25 (1979).

See, e.g., Raymond v. Eli Lilly & Company, 117 N.H. 164, 371 A.2d 170 (1977) (limitation period does not begin to run until plaintiff discovers cause of action).

Under the discovery rule a cause of action does not accrue “[u]ntil the plaintiff discovers or has a reasonable opportunity to discover that she has suffered a legal injury for which the defendant may be liable.” Raymond v. Eli Lilly & Co., 117 N.H. 164, 167, 371 A.2d 170, 172 (1977).